Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Hyperthyroidism can hide signs of high androgen levels in females.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Certain gene variations might be linked to severe acne in women but not in men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.